Skip to main content
. 2022 May 7;15:54. doi: 10.1186/s13045-022-01275-7

Fig. 2.

Fig. 2

Median anti-SARS-CoV-2 IgG-reactive antibody titers measured in binding antibody units/mL (BAU/mL) at 3–6 weeks after the 2nd dose according to SARS-CoV-2 breakthrough infection. Patients who did not developed SARS-CoV-2 infection (n = 1207) had a median of 730.81 BAU/mL (range 0–58,600) vs 1.83 BAU/mL (range 0–4854.93) in those who did develop breakthrough infection (n = 27) (p = 0.007)